MENU
LENZ
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
LENZ Therapeutics (LENZ) Earnings Date & Reports
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products... Show more
A.I. Advisor
published Earnings
LENZ is expected to report earnings to fall 2.93% to -99 cents per share on November 11
Q3'26
Est.
$-0.99
Q2'26
Beat
by $0.05
Q1'26
Missed
by $0.15
Q4'25
Missed
by $0.40
Q3'25
Missed
by $0.19
The last earnings report on August 11 showed earnings per share of -101 cents, beating the estimate of -107 cents. With 352.26K shares outstanding, the current market capitalization sits at 124.42M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
201 Lomas Santa Fe Drive
Phone
+1 858 925-7000
Employees
152
Web
https://www.lenz-tx.com